Cargando…
Optimal medical therapy after percutaneous coronary intervention in very elderly patients with coronary artery disease()
Background: It is still unclear whether optimal medical therapy (OMT) after percutaneous coronary intervention (PCI) has beneficial effects on long-term clinical outcomes in patients aged ≥80 years with coronary artery disease (CAD). Methods: This study analyzed the time to the first major adverse c...
Autores principales: | Nakamura, Takamitsu, Horikoshi, Takeo, Kobayahi, Tsuyoshi, Yoshizaki, Toru, Uematsu, Manabu, Watanabe, Yosuke, Nakamura, Jun, Makino, Aritaka, Saito, Yukio, Obata, Jun-ei, Sawanobori, Takao, Takano, Hajime, Umetani, Ken, Watanabe, Akinori, Asakawa, Tetsuya, Sato, Akira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731838/ https://www.ncbi.nlm.nih.gov/pubmed/36506909 http://dx.doi.org/10.1016/j.ijcrp.2022.200162 |
Ejemplares similares
-
A Stratified Analysis of the Risk Associated With Low Body Mass Index for Patients After Percutaneous Coronary Intervention
por: Horikoshi, Takeo, et al.
Publicado: (2023) -
A Propensity Score Matched Analysis of Statin Effects on Major Adverse Cardiac Events after Percutaneous Coronary Intervention in Patients Over 75 Years Old
por: Horikoshi, Takeo, et al.
Publicado: (2022) -
Improvement in Brachial Endothelial Vasomotor Function and Brachial-Ankle Pulse Wave Velocity Reduces the Residual Risk for Cardiovascular Events after Optimal Medical Treatment in Patients with Coronary Artery Disease
por: Nakamura, Takamitsu, et al.
Publicado: (2021) -
Persistent Dysfunction of Coronary Endothelial Vasomotor Responses is Related to Atheroma Plaque Progression in the Infarct-Related Coronary Artery of AMI Survivors
por: Horikoshi, Takeo, et al.
Publicado: (2019) -
Structural Thickening of Medial Layer in Coronary Artery With Spasm in Patients With Myocardial Infarction
por: Nakamura, Takamitsu, et al.
Publicado: (2021)